Intro offer
100 days of Premium for just $10.
Try all Premium features for over 3 months and analyze stocks without limits.
Try 100 days for $10

CN¥19.40
0.26%
Shanghai, Sep 17, 03:00 pm CST. Closed.
ISIN
CNE100000387
Symbol
600332

Guangzhou Baiyunshan Pharm-h Target price 2026 - Analyst rating & recommendation

Guangzhou Baiyunshan Pharm-h Classifications & Recommendation

Buy
71%
Hold
14%
Sell
14%

Guangzhou Baiyunshan Pharm-h Price Target

Target Price CN¥25.19
Price CN¥19.40
Potential
Number of Estimates 3
3 Analysts have issued a price target Guangzhou Baiyunshan Pharm-h 2027 . The average Guangzhou Baiyunshan Pharm-h target price is CN¥25.19. This is higher than the current stock price. The highest price target is
CN¥35.70 84.02%
register free of charge
, the lowest is
CN¥15.55 19.82%
register free of charge
.
A rating was issued by 7 analysts: 5 Analysts recommend Guangzhou Baiyunshan Pharm-h to buy, 1 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Guangzhou Baiyunshan Pharm-h stock has an average upside potential 2027 of . Most analysts recommend the Guangzhou Baiyunshan Pharm-h stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion CN¥ 77.66 80.07
3.55% 3.10%
EBITDA Margin 5.12% 6.42%
10.76% 25.49%
Net Margin 3.84% 3.66%
1.60% 4.72%

4 Analysts have issued a sales forecast Guangzhou Baiyunshan Pharm-h 2026 . The average Guangzhou Baiyunshan Pharm-h sales estimate is

CN¥80.1b
unlock
. This is
2.05% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CN¥85.0b 8.30%
unlock
, the lowest is
CN¥76.9b 2.05%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CN¥77.7b 3.55%
2026
CN¥80.1b 3.10%
unlock
2027
CN¥83.7b 4.55%
unlock
2028
CN¥90.5b 8.14%
unlock

4 Guangzhou Baiyunshan Pharm-h Analysts have issued a net profit forecast 2026. The average Guangzhou Baiyunshan Pharm-h net profit estimate is

CN¥2.9b
unlock
. This is
0.39% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CN¥3.3b 12.44%
unlock
, the lowest is
CN¥2.5b 13.99%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CN¥3.0b 5.21%
2026
CN¥2.9b 1.64%
unlock
2027
CN¥3.1b 5.04%
unlock
2028
CN¥3.6b 17.23%
unlock

Net Margin

2025 3.84% 1.60%
2026
3.66% 4.72%
unlock
2027
3.68% 0.55%
unlock
2028
3.99% 8.42%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CN¥ 1.84 1.80
5.75% 2.17%
P/E 10.78
EV/Sales 0.45

4 Analysts have issued a Guangzhou Baiyunshan Pharm-h forecast for earnings per share. The average Guangzhou Baiyunshan Pharm-h EPS is

CN¥1.80
unlock
. This is
0.55% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CN¥2.04 12.71%
unlock
, the lowest is
CN¥1.56 13.81%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CN¥1.84 5.75%
2026
CN¥1.80 2.17%
unlock
2027
CN¥1.90 5.56%
unlock
2028
CN¥2.22 16.84%
unlock

P/E ratio

Current 10.75 28.33%
2026
10.78 0.32%
unlock
2027
10.26 4.82%
unlock
2028
8.75 14.72%
unlock

Based on analysts' sales estimates for 2026, the Guangzhou Baiyunshan Pharm-h stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.46
2026
0.45 1.76%
unlock
2027
0.43 4.36%
unlock
2028
0.40 7.52%
unlock

P/S ratio

Current
2026
0.38 1.98%
unlock
2027
0.36 4.37%
unlock
2028
0.33 7.52%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today